Trans & non-binary midlife
When hormones shift, the body responds.
One doorway, two physiologically distinct stories. For trans women whose estrogen drops in midlife — dose changes, access loss, post-orchiectomy, aging on long-term HRT. And for trans men and non-binary AFAB readers whose ovaries are still in the picture, on or off testosterone, or who've had surgery that changed the math. Most menopause writing leaves you out. We're trying not to.
Before we start
The medical content across the rest of the site applies to the hormones and tissues you have, not to whose body the textbook assumed. This page is the translation. Jump to the section that fits — and skim the other one too if you're curious; the mechanisms overlap more than the standard menopause writing lets on.
Our stance
Four things we believe, and write to.
The physiology is real
When sex hormones shift, the body responds
Most of this site is written about what happens when estrogen falls — hot flashes, night sweats, sleep that breaks at 3 a.m., mood weather, joint pain, bone loss over time, vaginal and urinary tissue thinning, libido shifts, fog. The mechanism doesn't care about chromosomes or how the estrogen got into the body. And if you have ovaries — whether or not you're on testosterone, whether or not you menstruate — those ovaries can still age, slow, and eventually stop. Two different stories, one physiology.
Most menopause writing leaves you out
We're trying not to
The standard playbook assumes a cis woman with intact ovaries who's never been on exogenous hormones. That description fits a lot of our readers and it doesn't fit a lot of others. Rather than write a separate, sparse "trans corner" we've kept the substance on the shared pathways and used this page to flag what changes — for trans women on estrogen, for trans men and non-binary AFAB readers on (or off) testosterone, and for anyone post-hysterectomy or oophorectomy.
The evidence gap
We won't pretend the trials are here
The menopause literature was built on cis women. The trans health literature on exogenous hormones has focused mostly on starting and maintaining HRT, not on what happens in midlife. There's a small but growing body of work — case series, endocrinology guidance, lived-experience writing — and we'll cite what we have. Where we extrapolate, we'll flag it. What we won't do is leave the page blank because the randomised trial hasn't been run yet. For the broader appointment framing — hormones and body parts first, identity second — see gender & midlife.
A note on "midlife"
If you had gender-affirming surgery in your teens, twenties or thirties, the menopause-shaped part of this may already be your present, not something decades off. This page still applies to you.
Section A — Trans women & transfeminine readers
When estrogen drops, the picture is familiar.
If you've been on estrogen and the level falls — for any reason — the same vasomotor, sleep, mood, bone and GSM-adjacent picture the rest of this site is about can show up. Sometimes mildly, sometimes hard. The four scenarios we hear about most:
Tap the one that fits
Section B — Trans men, transmasculine & non-binary AFAB readers
Ovaries age on their own timeline, with or without T.
This is the part of the menopause conversation that almost everyone misses. For some, surgical menopause arrived in their twenties the day the ovaries came out. For others, testosterone stopped the periods but the ovaries kept aging in the background, and a real, clinical menopause shows up in the late 40s or early 50s with no period to signal it. Four scenarios worth naming:
Tap the one that fits
If you are on long-term testosterone and want the cis-male framing for age-related testosterone decline — the symptoms, the labs, the cautious approach — our andropause explainer covers it. Read it as a parallel, not a prescription: your management belongs with your gender-affirming prescriber.
Where the substance lives
This page is the front door. Here's the rest of the house.
The clinical content lives in the standard pathways. The mechanism and the toolkit don't change; we've flagged trans-specific considerations inside each one where the evidence supports it.
Hot flashes & night sweats
Vasomotor symptoms
The classic estrogen-shift picture. Triggers, what helps (hormonal and non-hormonal), when to push for a level check. The mechanism is the same; bring your numbers.
Read3 a.m. wakeups
Sleep in midlife
Why hormone-related sleep loss looks the way it does, what helps before you escalate to a sleep clinic, and how to talk about it without it being filed under anxiety.
ReadMood weather
Mood, anxiety, low days
Estrogen does real work in mood regulation. So does testosterone. When either drops or fluctuates, the floor can move. What's hormone-shaped, what's life-shaped, and when each calls for a different response.
ReadBones don't care
Bone density, joints, muscle
Long-term steady estrogen is part of what protects bone. If your level has been variable, low, or substituted with T alone post-oophorectomy, the DEXA conversation is the same one any midlife reader needs to have.
ReadTissue and the bits below
Genitourinary syndrome of menopause
Dryness, irritation, recurrent UTIs, painful sex, urinary urgency. Local vaginal estrogen is the most evidence-backed intervention here and is safe alongside testosterone or systemic estrogen alike.
ReadWhat's on the menu
Treatments primer
Estrogen formulations, progesterone (sometimes), local vaginal estrogen, testosterone, non-hormonal options for vasomotor symptoms, bone meds. Plain language, no gendered defaults.
ReadFind a doctor or specialist
Someone who'll have the conversation
A doctor or specialist who'll treat hormones-and-symptoms without making the appointment about your identity. The directory is the next step after the framing.
ReadWhat we won't do
A short list, so you know what you're reading.
- We won't prescribe. Dose changes, formulation switches, monitoring schedules — that's a conversation with a doctor or specialist who knows your history. We'll help you walk in prepared.
- We won't over-claim the evidence. The research on midlife hormone shifts in trans and non-binary people is thinner than either of us would like. Where we extrapolate, we'll flag it. Where there's direct evidence, we'll cite it.
- We won't lecture you about your body. You know what you've been through. We're here to fill in the menopause-shaped gap in the writing, not to teach you anything about your own life.
- We won't make this a separate room. The pathways, symptom guides, practitioner directory and chat all apply. This page exists to say that out loud and to give you a clear entry point. Not to fence you off.
The mechanism doesn't care about chromosomes or how the estrogen got into the body. When sex hormones shift, the body responds.
Further reading & listening
The people doing this well, so you can read them too.
We won't be the only voice you want on this. Two sites in particular have been quietly building the field for years — Tania Glyde's Queer Menopause and ACON's TransHub — and there's a small but growing podcast bench worth your time.
Reading
Queer Menopause
Tania Glyde
The closest thing this field has to a canonical site. Therapist-led, research-backed, cited in NICE consultations. Covers queer, trans, non-binary and intersex experiences of menopause without flattening them into one story.
VisitQueer Menopause — resources hub
Tania Glyde
The curated shelf inside Queer Menopause: books, articles, podcasts, first-person pieces and practitioner directories for LGBTQIA+ readers. Kept more current than any single review or clinic page.
VisitGenderqueer Menopause
Tania Glyde
Companion project centred on genderqueer, non-binary and gender-non-conforming experiences of midlife hormone shifts. Research, first-person accounts, and a practitioner-training strand aimed at closing the same gap this page names.
VisitMenopause & Oestrogen Cessation
TransHub (ACON, Australia)
Clinician-reviewed plain-language guide written for trans readers. Covers both the estrogen-drop story and the still-have-ovaries story on one page, with practical advice on finding affirming care.
VisitMenopause When You're Trans or Nonbinary: Ask the Expert
Dr. E. Mimi Arquilla, DO — Healthline
Expert-reviewed explainer with clean terminology and a useful breakdown of which scenarios produce which symptoms. Good for sharing with a doctor who needs the primer.
VisitWhat trans people need to know about menopause
Bec Roldan — Script Health
Newer (2026) split-format piece that does the transmasc and transfemme stories side by side. Particularly good on the testosterone-and-aging-ovaries scenario, which most other guides skim.
VisitListening
Testosterone, Perimenopause & Menopause
Our Womanity with Dr. Rachel Pope — Ep #6 with Dr. Tami Rowen (UCSF)
Dr. Tami Rowen is a gynecologist who works across menopause and trans health. The episode is the clearest hour we've found on what testosterone actually does in midlife — for cis and trans patients both.
VisitMenopause from a transgender perspective
The Menopause Space — S3E6 with Kell Smith
Conversation with a trans woman about what menopause-shaped symptoms look like from the inside, including the workplace angle. Warm and specific.
VisitTate Smith on the trans male experience of menopause
Middling Along — Emma Cronin
One of very few episodes anywhere on the transmasculine experience of midlife hormone shifts. Tate Smith is a trans man and educator; the conversation is plain, kind, and useful.
VisitGender, Hormones & Midlife Health
Let's Talk Menopause with Dr. Jill Liss
Useful primer on how gender and hormone history change the midlife picture, aimed at a general audience. Good first listen before the more specialized episodes above.
VisitResearch & clinical guidance
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons (clinical practice guideline)
Hembree et al., Endocrine Society — J Clin Endocrinol Metab, 2017
The reference endocrinology guideline for long-term estrogen and testosterone therapy in trans patients. The midlife section is thin (acknowledged in the document itself) but it's the standard practitioners are working from.
VisitCardiovascular disease in transgender people receiving hormone therapy
Connelly et al. — BMJ, 2019
Cardiovascular risk on long-term estrogen and testosterone — directly relevant to the midlife conversation about HRT continuation, cholesterol and blood pressure.
VisitMenopause and the transgender and gender diverse population: a scoping review
Cocchetti et al. — Maturitas, 2021
The current best summary of what the literature does and doesn't say about menopause in trans and gender-diverse people. Honest about the gaps.
VisitQueer Menopause research library
Tania Glyde and collaborators
Curated list of peer-reviewed papers, qualitative studies and grey literature on LGBTQIA+ menopause — kept more current than any single review article.
VisitOvarian reserve markers in transgender men on testosterone therapy
Yaish et al. — Human Reproduction, 2021
After roughly a year on testosterone, AMH and antral follicle count (the standard markers of ovarian reserve) stayed fairly preserved. The modest decline observed was mostly driven by patients who already had PCOS before starting T, not by testosterone itself. Small study, short follow-up — the best current picture, not a settled one.
VisitHysterectomy with bilateral oophorectomy as gender-affirming surgery
Jeftovic et al. — BioMed Research International, 2018
124 patients who had hysterectomy with bilateral oophorectomy as gender-affirming surgery. Mean age 28.5, range 18 to 43. Surgical menopause in this community starts young.
VisitBilateral oophorectomy at gender-affirming hysterectomy in patients 18–30
O'Brien et al. — J Pediatr Adolesc Gynecol, 2023 (conference abstract)
Of transgender and gender-diverse patients aged 18 to 30 who had gender-affirming hysterectomy, 68% chose to also have both ovaries removed at the same time. More common among those with a male gender identity and those already on testosterone.
VisitOvarian histology in transgender people on testosterone — changes track with age, not time on T
Borrás et al. — Maturitas, 2021
Histological changes in ovarian tissue correlated with chronological age, not with duration of testosterone therapy. Supports the picture that ovaries age on their own clock regardless of T. Small sample, single-centre.
VisitExternal links are exactly that — external. We don't control what's on those pages and we don't take payment for including them. If a link breaks or a resource has shifted in a direction we'd no longer recommend, please tell us.
More in Nila's library
Everything we've tagged trans & non-binary midlife, sorted into shelves.
The curated set above is what we'd hand a friend on day one. The library shelves are wider — peer-reviewed papers, mainstream long-reads, podcasts and documentaries — and stay current as we add to them.
Your body is doing what bodies on shifting hormones do. You don't have to translate the menopause writing to find yourself in it. We'll do that work.
If a page on Nila uses framing that lands wrong for you, please tell us and we read everything. We're going to get parts of this wrong before we get it right, and we'd rather hear from you than guess.
Other doorways